CDC ends universal newborn hepatitis B vaccine recommendations
The new guidance marks a major policy shift to the vaccine framework that has been in place since 1991.
Therapy Area
Precision medicine approaches needed in oncology to match evolving SoC
First gonorrhoea antibiotics in decades herald new era of treatment
Sanofi shares fall 6% after double setback for MS drug tolebrutinib
Mirum to buy Bluejay for up to $820m in rare liver disease push
Pfizer gains another obesity asset with $2bn deal for YaoPharma’s GLP-1RA
Crescent and Kelun-Biotech swap cancer asset rights in double deal
WHO backs use of GLP-1RAs for weight loss despite shortage warning
